{
    "nctId": "NCT04395339",
    "briefTitle": "GM1 Prophylaxis for WBRT Related Cognitive Dysfunction",
    "officialTitle": "Ganglioside-Monosialic Acid Prophylaxis for Cognitive Dysfunction Related to Whole Brain Radiotherapy in Breast Cancer Patients With Brain Metastases \uff0ca Multi-center\uff0cRandomized\uff0cSingle Blind\uff0cPhase III Clinical Trail",
    "overallStatus": "TERMINATED",
    "conditions": "Brain Metastases, Radiotherapy Side Effect, Cognitive Impairment, Gangliosidosis, GM1, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 51,
    "primaryOutcomeMeasure": "HVLT R-DR",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age between 18-75,with histological affirmative breast cancer ,and over 4 brain metastases ,need for WBRT suggested by radiotherapy oncologist ;\n* Estimated survival time over 6months;\n* Abundant hematological function:Absolute Neutrophil Count\u22652\u00d7109/L ;platelet count\u2265100\u00d7109/L and hemoglobulin\u22659 g/dL;\n* Abundant liver function\uff1atotal bilrubin\u2264ULN\uff1bASTandALT\u22642.5ULN\uff1bAKP\u22645ULN\n* Can cope with HVLT-RDR and ADAS-Cog evaluation\n* No prior therapy could induce neurological damage,within 4 weeks\n* No more that 1 degree peripheral neuropathy or any other diseases or symptoms that could hinder the evaluation of neurological AE\n* No more treatment or nursing is allowed after enrolling this trail\n* Written Informed Consent signed\n\nExclusion Criteria:\n\n* PS score over 2,and estimated no attenuation by WBRT\n* Women with pregnancy or breast feeding\n* Unwilling to contraception measurement\n* Abnormal baseline impairment of cognitive impairment\n* Allergy to experiment agents or components\n* Unsuitable to GM1 treatment, evaluated by investigators\n* Active infection\n* RT dose over 30Gy",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}